ImmuCell
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $6,444 | $8,067 | $7,751 | $6,011 |
Gross Profit | 2,817 | 3,353 | 2,832 | 1,583 |
EBITDA | 1,296 | 1,793 | 1,702 | 100 |
EBIT | 628 | 1,117 | 1,028 | -574 |
Net Income | 501 | 1,446 | 515 | -701 |
Net Change In Cash | 6,444 | 8,067 | 7,751 | 6,011 |
Free Cash Flow | 1,446 | 1,244 | -199 | -727 |
Cash | 5,998 | 4,599 | 3,758 | 3,808 |
Basic Shares | 9,031 | 8,980 | 8,935 | 8,164 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $26,493 | $17,471 | $18,568 | $19,243 |
Gross Profit | 7,941 | 4,396 | 7,649 | 8,656 |
EBITDA | 1,109 | -2,504 | 188 | 2,717 |
EBIT | -1,577 | -5,221 | -2,299 | 245 |
Net Income | -2,156 | -5,774 | -2,494 | -78 |
Net Change In Cash | 26,493 | 17,471 | 18,568 | 19,243 |
Free Cash Flow | -107 | -6,566 | -5,519 | -1,654 |
Cash | 3,758 | 978 | 5,792 | 10,185 |
Basic Shares | 8,167 | 7,747 | 7,745 | 7,592 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $0.06 |
2025-03-31 | $0.16 |
2024-12-31 | $0.05 |
2024-09-30 | -$0.08 |
